TRENDS

• With Entry of SGLT-2 Inhibitors, Competition Heating Up Again in Oral Anti-Diabetes Drug Market
  September 12, 2014

• Molecular-Targeted Treatments for Refractory Thyroid Cancer Debut, Giving Patients Hope
  September 5, 2014

• Competition Likely to Heat Up in RA Biologics Market Although Growth Continues
  August 29, 2014

• Smaller Drug Makers Actively Expanding Overseas Focus, Shedding Conventional Business Models
  August 18, 2014

• Old Giving Way to New in Osteoporosis Market as Competition among New Drugs Launched Since 2010 Increases
  August 8, 2014

• Development Activity in Pulmonary Hypertension Market Accelerates with Debut of Japan’s First CTEPH Treatment
  July 23, 2014

• Will Blopress AG Launched Prior to Patent Expiration Dominate the Market?
  July 11, 2014

• Entry of Lixiana Will Further Intensify Competition in Market for NOACs
  July 4, 2014

• With Sales of Aricept, Pariet Plummeting, Eisai to Focus on Investment in FY2014 with an Eye to Growth Track in FY2015
  June 27, 2014

• MTPC Predicts Remicade Biosimilar “Will Not Have a Major Impact”
  June 20, 2014

• Novo Nordisk Launches Hemophilia A Treatment NovoEight; Will Compete Directly with Baxter’s Advate
  June 13, 2014

• Different Stances on Biosimilars Setting Domestic Generic Houses Apart as “Post-Small Molecule” Era Approaches
  June 6, 2014

• Risk Management Could Be Key to Success of Highly Anticipated New NSCLC Treatment Giotrif
  May 30, 2014

• Cost-Reduction Becoming a Top Priority for Domestic Drug Makers Due to Sluggish Sales of Long-Listed Drugs, Impact of NHI Pricing System Reform
  May 28, 2014

• Foreign Drug Makers Seeking to Offset Risk in US, European Markets by Driving Growth in “Attractive” Japanese Market
  May 23, 2014

• With Growth in the Number of CMRs Slowing, Can JCSOA Reach Its Goal of “5,000 CMRs by the End of 2015”?
  May 16, 2014

• Shionogi’s New Midterm Business Plan Aims for Realistic Growth Targets for Domestic Sales Focusing on “Strategic Products”
  April 24, 2014

ページ